Question 1

What is Jianming Xu?

Accepted Answer

Jianming Xu is a Person.

Question 2

How often does Jianming Xu appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Jianming Xu first tracked by Ergen?

Accepted Answer

First tracked on Jun 24, 2026.

Question 4

When was Jianming Xu last mentioned in news?

Accepted Answer

Last active on Jun 25, 2026.

Question 5

What is Jianming Xu's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Jianming Xu in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Jianming Xu?

Accepted Answer

HUTCHMED Fanregratinib Phase II Results (Jun 24, 2026, 6 articles).

Question 8

How did the "HUTCHMED Fanregratinib Phase II Results" event impact Jianming Xu?

Accepted Answer

Professor Jianming Xu, the leading Principal Investigator of the study, provided expert commentary on the positive clinical results of fanregratinib, highlighting its therapeutic value.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.